IP Library Granted Patent US 11,203,751
Granted Patent B2
US 11,203,751 · App. 17/336,244 · Granted Dec 21, 2021

Automated cell processing methods, modules, instruments, and systems

Inventors: Jorge Bernate (Boulder, CO); Kevin Ness (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Don Masquelier (Boulder, CO); Ryan Gill (Boulder, CO)
Assignee: Inscripta, Inc.
C12N15/1082C12M23/44C12M33/14C12M35/00C12M37/04C12M41/36C12M41/48C12M43/00C12N9/22C12N15/11C40B40/02C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,203,751
App. No.
17/336,244
Granted
Dec 21, 2021
Kind
B2
Abstract

In an illustrative embodiment, automated multi-module cell editing instruments are provided to automate multiple edits into nucleic acid sequences inside one or more cells.

Claims (60)

1. A method of editing mammalian cells in an automated stand-alone multi-module cell editing instrument comprising:

providing an automated stand-alone multi-module cell editing instrument comprising:

a housing configured to house all or some of the modules;

a receptacle configured to receive the mammalian cells;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a growth module for growing cells for transformation;

a transformation module configured to introduce the expression vectors into the mammalian cells;

a nuclease-directed editing module configured to allow the introduced expression vectors to edit nucleic acids in the mammalian cells;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the receptacle configured to receive the mammalian cells to the growth module; from the growth module to the transformation module; from the one or more receptacles configured to receive expression vectors to the transformation module; and from the transformation module to the nuclease-directed editing module without user intervention;

loading mammalian cells into the receptacle configured to receive the mammalian cells;

loading the expression vectors into the one or more receptacles configured to receive expression vectors;

transferring, via the liquid handling system, the mammalian cells from the receptacle configured to receive the mammalian cells to the growth module;

growing the mammalian cells;

transferring, via the liquid handling system, the grown mammalian cells from the growth module to the transformation module;

transferring, via the liquid handling system, the expression vectors from the one or more receptacles to the transformation module;

transforming the grown mammalian cells with the expression vectors to produce transformed mammalian cells;

transferring, via the liquid handling system, the transformed mammalian cells from the transformation module into the nuclease-directed editing module; and

editing the transformed mammalian cells to produce edited mammalian cells.

2. The method of editing mammalian cells of claim 1 , wherein the automated liquid handling system comprises a sipper or pipettor.

3. The method of editing mammalian cells of claim 1 , wherein the nuclease-directed editing module is also a recovery module.

4. The method of editing mammalian cells of claim 1 , wherein the automated stand-alone multi-module cell editing instrument further comprises a recovery module separate from the editing module and further comprising after the editing step, the step of transferring the edited mammalian cells from the nuclease-directed editing module to the recovery module.

5. The method of editing mammalian cells of claim 1 , wherein the growth module is separate from the transformation module.

6. The method of editing mammalian cells of claim 1 , wherein the transformation module performs a process selected from electroporation, lipofection, optoporation, injection, microprecipitation, magnetofection, microinjection, particle bombardment, sonoporation, laser-induced poration, bead transfection, calcium phosphate and calcium chloride co-precipitation, and DEAE-dextran-mediated transfection.

7. The method of editing mammalian cells of claim 6 , wherein the transformation module performs electroporation.

8. The method of editing mammalian cells of claim 1 , wherein the automated stand-alone multi-module cell editing instrument further comprises a selection module.

9. The method of editing mammalian cells of claim 1 , wherein the growth module and the transformation module are combined.

10. The method of editing mammalian cells of claim 1 , wherein the growth module is combined with the transformation module.

11. The method of editing mammalian cells of claim 1 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

12. A method of editing mammalian cells in an automated stand-alone multi-module cell editing instrument comprising:

providing an automated stand-alone multi-module cell editing instrument comprising:

a housing configured to house all or some of the modules;

a receptacle configured to receive the mammalian cells;

one or more receptacles configured to receive expression vectors, wherein the expression vectors introduce a desired DNA change to the target region and remove a proto-spacer motif (PAM) region from the target region;

a transformation module configured to introduce the expression vectors into the mammalian cells;

a nuclease-directed editing module configured to allow the introduced expression vectors to edit nucleic acids in the mammalian cells;

a selection module to select for edited mammalian cells;

a processor configured to operate the automated multi-module cell editing instrument based on user input and/or selection of a pre-programmed script; and

an automated liquid handling system to move liquids from the receptacle configured to receive the mammalian cells to the transformation module; from the one or more receptacles configured to receive expression vectors to the transformation module; from the transformation module to the nuclease-directed editing module; and from the nuclease-directed editing module to the selection module without user intervention;

loading mammalian cells into the receptacle configured to receive the mammalian cells;

loading the expression vectors comprising the vector backbone and the editing cassette into the one or more receptacles configured to receive expression vectors;

transferring, via the liquid handling system, the mammalian cells from the receptacle configured to receive the mammalian cells to the transformation module;

transferring, via the liquid handling system, the expression vectors from the one or more receptacles to the transformation module;

transforming the mammalian cells with the expression vectors to produce transformed mammalian cells;

transferring, via the liquid handling system, the transformed mammalian cells from the transformation module into the nuclease-directed editing module;

editing the transformed mammalian cells; and

selecting edited mammalian cells.

13. The method of editing mammalian cells of claim 12 , wherein the automated liquid handling system comprises a sipper or pipettor.

14. The method of editing mammalian cells of claim 12 , wherein the growth module is combined with the transformation module.

15. The method of editing mammalian cells of claim 12 , wherein the transformation module, nuclease-directed editing module and selection module are combined.

16. The method of editing mammalian cells of claim 12 , wherein the nuclease-directed editing module is also a recovery module.

17. The method of editing mammalian cells of claim 12 , wherein the transformation module performs a process selected from electroporation, lipofection, optoporation, injection, microprecipitation, magnetofection, microinjection, particle bombardment, sonoporation, laser-induced poration, bead transfection, calcium phosphate and calcium chloride co-precipitation, and DEAE-dextran-mediated transfection.

18. The method of editing mammalian cells of claim 12 , wherein the automated stand-alone multi-module cell editing instrument further comprises a separate growth module and further comprising before the transformation step, the step of transferring the mammalian cells from the receptacle configured to receive the mammalian cells to the growth module.

19. The method of editing mammalian cells of claim 18 , wherein the growth module, transformation module and nuclease-directed editing module are combined.

20. The method of editing mammalian cells of claim 19 , wherein the selection module is combined with the growth module, transformation module and nuclease-directed editing module.

21. The method of editing mammalian cells of claim 12 , wherein the expression vectors are viral vectors.

22. The method of editing mammalian cells of claim 21 , wherein the viral vector is selected from a retrovirus vector, replication defective retrovirus vector, adenovirus vector, replication defective adenovirus vector, and adeno-associated virus vector and a lentivirus vector.

23. The method of editing mammalian cells of claim 12 , wherein the mammalian cells are human cells.

24. The method of editing mammalian cells of claim 12 , wherein a nuclease is delivered to the mammalian cells as a protein.

25. The method of editing mammalian cells of claim 12 , wherein the nuclease is a MAD7 nuclease.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2021
From: BERNATE, JORGE; NESS, KEVIN; BELGRADER, PHILLIP; MASQUELIER, DON; GILL, RYAN
To: INSCRIPTA, INC.
Reel/Frame 056406/0920 →
Continuity (26)
Continuation 17200443 · Mar 12, 2021
Continuation 17131582 · Dec 22, 2020
Continuation 16988694 · Aug 9, 2020
Continuation 16837985 · Apr 1, 2020
Continuation 16822249 · Mar 18, 2020
Continuation 16750369 · Jan 23, 2020
Continuation 16680643 · Nov 12, 2019
Continuation 16666964 · Oct 29, 2019
Continuation 16571091 · Sep 14, 2019
Continuation 16423289 · May 28, 2019
Continuation 16269655 · Feb 7, 2019
Continuation 16024816 · Jun 30, 2018
Provisional Application 62527339 · Jun 30, 2017
Provisional Application 62551069 · Aug 28, 2017
Provisional Application 62566374 · Sep 30, 2017
Provisional Application 62566375 · Sep 30, 2017
Provisional Application 62566688 · Oct 2, 2017
Provisional Application 62567697 · Oct 3, 2017
Provisional Application 62620370 · Jan 22, 2018
Provisional Application 62649731 · Mar 29, 2018
Provisional Application 62671385 · May 14, 2018
Provisional Application 62648130 · Mar 26, 2018
Provisional Application 62657651 · Apr 13, 2018
Provisional Application 62657654 · Apr 13, 2018
Provisional Application 62689068 · Jun 23, 2018
Related Publication 20210284994A1 · Sep 16, 2021